Loading…
Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery
Remifentanil is an ultrashort-acting synthetic opioid. It is metabolized by nonspecific tissue and plasma esterases. Remifentanil's metabolism is responsible for its unique pharmacokinetic profile and flat, context-sensitive half-time. Since its introduction into clinical practice, remifentanil...
Saved in:
Published in: | Local and regional anesthesia 2010-01, Vol.3, p.35-43 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c403t-dd47a255a771897564a4b1390f5f65de517e8a55b92c024a7a5bcf777bb7435a3 |
---|---|
cites | |
container_end_page | 43 |
container_issue | |
container_start_page | 35 |
container_title | Local and regional anesthesia |
container_volume | 3 |
creator | Sivak, Erica L Davis, Peter J |
description | Remifentanil is an ultrashort-acting synthetic opioid. It is metabolized by nonspecific tissue and plasma esterases. Remifentanil's metabolism is responsible for its unique pharmacokinetic profile and flat, context-sensitive half-time. Since its introduction into clinical practice, remifentanil has been used for a variety of anesthetic and analgesic applications; however, concerns regarding a potential for rapid induction of tolerance and/or induced hyperalgesia, coupled with an ultrarapid offset of effect, make the drug less than optimal for use in the pharmacologic management of pain. |
doi_str_mv | 10.2147/LRA.S7709 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3417946</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2222688930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-dd47a255a771897564a4b1390f5f65de517e8a55b92c024a7a5bcf777bb7435a3</originalsourceid><addsrcrecordid>eNpdkUFr3DAQhUVpaUKaQ_9AMfTSHDaRZMljXwohNG1hIZC2ZzG2RxsFW9pK9pa95pdHu5uGtHORePPNY4bH2HvBz6VQcLG8vTz_AcCbV-xYCKgXIIR8_eJ_xE5Tuue5NJdQqbfsSMpG6LqCY_ZwSxtHf4pgi-mOCrLWddhtC_R9kdDStN21Io3Okp_Qu6GwIe7ZdaRN1lzwe3qKhNOYhd3AGp0v-jk6v9o30U4U80ToKKuUDv5zXFHcvmNvLA6JTp_eE_br-svPq2-L5c3X71eXy0WneDkt-l4BSq0RQNQN6EqhakXZcKttpXvSAqhGrdtGdlwqBNRtZwGgbUGVGssT9vngu57bkfourxpxMOvoRoxbE9CZfzve3ZlV2JhSCWhUlQ0-PRnE8HumNJnRpY6GAT2FORnBSy04cLlDP_6H3oc5-nyekbmqum5KnqmzA9XFkFIk-7yM4GYXrsnhmn24mf3wcvtn8m-U5SOKQ6Dy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2222688930</pqid></control><display><type>article</type><title>Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery</title><source>Taylor & Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Sivak, Erica L ; Davis, Peter J</creator><creatorcontrib>Sivak, Erica L ; Davis, Peter J</creatorcontrib><description>Remifentanil is an ultrashort-acting synthetic opioid. It is metabolized by nonspecific tissue and plasma esterases. Remifentanil's metabolism is responsible for its unique pharmacokinetic profile and flat, context-sensitive half-time. Since its introduction into clinical practice, remifentanil has been used for a variety of anesthetic and analgesic applications; however, concerns regarding a potential for rapid induction of tolerance and/or induced hyperalgesia, coupled with an ultrarapid offset of effect, make the drug less than optimal for use in the pharmacologic management of pain.</description><identifier>ISSN: 1178-7112</identifier><identifier>EISSN: 1178-7112</identifier><identifier>DOI: 10.2147/LRA.S7709</identifier><identifier>PMID: 22915867</identifier><language>eng</language><publisher>New Zealand: Taylor & Francis Ltd</publisher><subject>Review</subject><ispartof>Local and regional anesthesia, 2010-01, Vol.3, p.35-43</ispartof><rights>2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2010 Sivak and Davis, publisher and licensee Dove Medical Press Ltd. 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-dd47a255a771897564a4b1390f5f65de517e8a55b92c024a7a5bcf777bb7435a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2222688930/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2222688930?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,725,778,782,790,883,25736,27905,27907,27908,36995,36996,44573,53774,53776,74877</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22915867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sivak, Erica L</creatorcontrib><creatorcontrib>Davis, Peter J</creatorcontrib><title>Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery</title><title>Local and regional anesthesia</title><addtitle>Local Reg Anesth</addtitle><description>Remifentanil is an ultrashort-acting synthetic opioid. It is metabolized by nonspecific tissue and plasma esterases. Remifentanil's metabolism is responsible for its unique pharmacokinetic profile and flat, context-sensitive half-time. Since its introduction into clinical practice, remifentanil has been used for a variety of anesthetic and analgesic applications; however, concerns regarding a potential for rapid induction of tolerance and/or induced hyperalgesia, coupled with an ultrarapid offset of effect, make the drug less than optimal for use in the pharmacologic management of pain.</description><subject>Review</subject><issn>1178-7112</issn><issn>1178-7112</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUFr3DAQhUVpaUKaQ_9AMfTSHDaRZMljXwohNG1hIZC2ZzG2RxsFW9pK9pa95pdHu5uGtHORePPNY4bH2HvBz6VQcLG8vTz_AcCbV-xYCKgXIIR8_eJ_xE5Tuue5NJdQqbfsSMpG6LqCY_ZwSxtHf4pgi-mOCrLWddhtC_R9kdDStN21Io3Okp_Qu6GwIe7ZdaRN1lzwe3qKhNOYhd3AGp0v-jk6v9o30U4U80ToKKuUDv5zXFHcvmNvLA6JTp_eE_br-svPq2-L5c3X71eXy0WneDkt-l4BSq0RQNQN6EqhakXZcKttpXvSAqhGrdtGdlwqBNRtZwGgbUGVGssT9vngu57bkfourxpxMOvoRoxbE9CZfzve3ZlV2JhSCWhUlQ0-PRnE8HumNJnRpY6GAT2FORnBSy04cLlDP_6H3oc5-nyekbmqum5KnqmzA9XFkFIk-7yM4GYXrsnhmn24mf3wcvtn8m-U5SOKQ6Dy</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Sivak, Erica L</creator><creator>Davis, Peter J</creator><general>Taylor & Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100101</creationdate><title>Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery</title><author>Sivak, Erica L ; Davis, Peter J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-dd47a255a771897564a4b1390f5f65de517e8a55b92c024a7a5bcf777bb7435a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sivak, Erica L</creatorcontrib><creatorcontrib>Davis, Peter J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Local and regional anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sivak, Erica L</au><au>Davis, Peter J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery</atitle><jtitle>Local and regional anesthesia</jtitle><addtitle>Local Reg Anesth</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>3</volume><spage>35</spage><epage>43</epage><pages>35-43</pages><issn>1178-7112</issn><eissn>1178-7112</eissn><abstract>Remifentanil is an ultrashort-acting synthetic opioid. It is metabolized by nonspecific tissue and plasma esterases. Remifentanil's metabolism is responsible for its unique pharmacokinetic profile and flat, context-sensitive half-time. Since its introduction into clinical practice, remifentanil has been used for a variety of anesthetic and analgesic applications; however, concerns regarding a potential for rapid induction of tolerance and/or induced hyperalgesia, coupled with an ultrarapid offset of effect, make the drug less than optimal for use in the pharmacologic management of pain.</abstract><cop>New Zealand</cop><pub>Taylor & Francis Ltd</pub><pmid>22915867</pmid><doi>10.2147/LRA.S7709</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1178-7112 |
ispartof | Local and regional anesthesia, 2010-01, Vol.3, p.35-43 |
issn | 1178-7112 1178-7112 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3417946 |
source | Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central |
subjects | Review |
title | Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T22%3A14%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20the%20efficacy%20and%20safety%20of%20remifentanil%20for%20the%20prevention%20and%20treatment%20of%20pain%20during%20and%20after%20procedures%20and%20surgery&rft.jtitle=Local%20and%20regional%20anesthesia&rft.au=Sivak,%20Erica%20L&rft.date=2010-01-01&rft.volume=3&rft.spage=35&rft.epage=43&rft.pages=35-43&rft.issn=1178-7112&rft.eissn=1178-7112&rft_id=info:doi/10.2147/LRA.S7709&rft_dat=%3Cproquest_pubme%3E2222688930%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-dd47a255a771897564a4b1390f5f65de517e8a55b92c024a7a5bcf777bb7435a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2222688930&rft_id=info:pmid/22915867&rfr_iscdi=true |